You are here: Industry Insights > china

News List

China Cord Blood Corporation Files Its Annual Report on Form 20-F en-cphi.cn
July 26, 2017
China Cord Blood Corporation announced that the Company filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission.
STA Signs Supply Agreement with TESARO en-cphi.cn
July 24, 2017
STA Pharmaceutical Co., Ltd. (STA) announces it signed a supply agreement with the oncology-focused biopharmaceutical company, TESARO, Inc. (TESARO) for certain starting and intermediate materials for ZEJULA™ (niraparib).
Taipei hosts BioTaiwan, China 2017 with 600 firms' participation biospectrumasia
July 18, 2017
BioTaiwan, China Trade Show has been instrumental in bringing international perspective and creating relationships with local talent.
Australia’s Cochlear plans expansion in China biospectrumasia
July 17, 2017
China is already among Cochlear’s top five international markets and is its fastest growing market by volume, with potential to deliver more strong growth over the next decade.
ShangPharma Innovation enters into partnership with UCSF biospectrumasia
July 14, 2017
The partnership helps advance a major new initiative at UCSF to bridge academic research with industrial development.
Australia’s Cochlear plans expansion in China biospectrumasia
July 14, 2017
China is already among Cochlear’s top five international markets and is its fastest growing market by volume, with potential to deliver more strong growth over the next decade.
Sanpower Group completes acquisition of Dendreon from Valeant pharmaasia
July 13, 2017
Chinese company completes acquisition of U.S. firm providing FDA-approved cellular immunotherapy for prostate cancer.
NeuroVive and Yungjin Pharm start clinical development pharmaasia
July 13, 2017
NeuroVive and Yungjin Pharm starts clinical development in Genetic Mitochondrial disease.
Guanzhou International Bio-Forum Permanently Settling in Guangzhou International Bio Island en-cphi.cn
July 05, 2017
The 10th China Bio-Industry Convention and the first Guanzhou International Bio-Forum was held on July 3 in Guangzhou, China. As an emerging strategic developmental focus of Guangzhou, the output value of the biomedical industry is expected to reach trill
Baheal Group brings Watson for Genomics to China pharmaasia
July 04, 2017
Baheal will serve as the primary channel partner for Watson for Genomics in China, building on the company's momentum bringing Watson to the market.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page